Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Glenn C Terry, MD
Global Alliance for Regenerative Medicine (GARM)
Principal Investigator - Robert W Alexander, MD
GARM USA
Principal Investigator - Ryan JP Welter, MD, PhD
Regeneris Medical
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Regeneris Medical
North Attleboro, Massachusetts, United States
Recruiting - Regeneris Medical
North Attleboro, Massachusetts, United States
Glenn C Terry, MDRobert W Alexander, MDRyan JP Welter, MD,PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Mar 2017
- Primary completion
- 31 Aug 2021
- Completion
- 31 Dec 2022
- Last update posted
- 18 Jan 2020
- Registered enrollment
- 300
- Registry id
- NCT03090672
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.